Background: RNA-binding proteins (RBPs) play important roles in cellular homeostasis by regulating the expression of thousands of transcripts, which have been reported to be involved in human tumorigenesis. Despite previous reports of the dysregulation of RBPs in cancers, the degree of dysregulation of RBPs in cancers and the intrinsic relevance between dysregulated RBPs and clinical TNM information remains unknown. Furthermore, the co-expressed networks of dysregulated RBPs with transcriptional factors and lncRNAs also require further investigation. Results: Here, we firstly analyzed the deviations of expression levels of 1,542 RBPs from 20 cancer types and found that (1) RBPs are dysregulated in almost all 20 cancer types, especially in BLCA, COAD, READ, STAD, LUAD, LUSC and GBM with proportion of deviation larger than 300% compared with non-RBPs in normal tissues. (2) Up-and down-regulated RBPs also show opposed patterns of differential expression in cancers and normal tissues. In addition, down-regulated RBPs show a greater degree of dysregulated expression than up-regulated RBPs do. Secondly, we analyzed the intrinsic relevance between dysregulated RBPs and clinical TNM information and found that (3) Clinical TNM information for two cancer types-CHOL and KICH-is shown to be closely related to patterns of differentially expressed RBPs (DE RBPs) by co-expression cluster analysis. Thirdly, we identified ten key RBPs (seven downregulated and three up-regulated) in CHOL and seven key RBPs (five down-regulated and two up-regulated) in KICH by analyzing co-expression correlation networks. Fourthly, we constructed the co-expression networks of key RBPs between 1,570 TFs and 4,147 lncRNAs for CHOL and KICH, respectively. Conclusions: These results may provide an insight into the understanding of the functions of RBPs in human carcinogenesis. Furthermore, key RBPs and the co-expressed networks offer useful information for potential prognostic biomarkers and therapeutic targets for patients with cancers at the N and M stages in two cancer types CHOL and KICH. PeerJ reviewing PDF | 24 25 ABSTRACT 26 Background: RNA-binding proteins (RBPs) play important roles in cellular homeostasis by 27 regulating the expression of thousands of transcripts, which have been reported to be involved in human 28 tumorigenesis. Despite previous reports of the dysregulation of RBPs in cancers, the degree of 29 dysregulation of RBPs in cancers and the intrinsic relevance between dysregulated RBPs and clinical 30 TNM information remains unknown. Furthermore, the co-expressed networks of dysregulated RBPs with 31 transcriptional factors and lncRNAs also require further investigation.
In order to investigate the degree of dysregulation of RBPs, we computed the standard deviation of 145 differentially expressed genes listed in Table 1 using 'std' function in software 'MATLAB' version 146 R2015b, respectively. In detail, we firstly computed the standard deviation of differentially expressed 147 RBPs in 20 cancers and paired normal tissues ( Fig. 2A) . Similarly, we next computed the standard 148 deviation of differentially expressed non-RBPs in 20 cancers and paired normal tissues (Fig. 2B) .
149
The definition of the standard deviation is as follows: 154 for RBP expression data is presented in additional files (Table S1) 155
In order to more clearly see the expression differences of RBPs and non-RBPs in cancers and normal 156 tissues, we further computed their relative deviations. In detail, we first computed the relative deviation of 157 RBPs in cancers and paired normal tissues, and then we computed the relative deviation of non-RBPs in 158 cancers and normal tissues (Fig. 2C) . The relative proportion of deviation is computed using the 159 following function:
. Here, and are the standard deviations of the gene expressions in 
161
Similarly, in order to investigate the expression differences of up-and down-regulated RBPs, we also 162 computed the standard deviation of them in cancers and normal tissues, respectively ( Fig. 2(D,E) ).
163 Finally, the mean expression values of up-and down-regulated RBPs in 20 cancers and paired normal 164 tissues were computed and presented in Fig. 2(F,G) . 183 Clinical TNM information processing 184 Clinical TNM information for 5,093 patients exhibiting 13 types of cancers downloaded from the 185 TCGA database presented in additional files (Table S4 ). Generally, in the TNM system, 'T' refers to a 186 primary tumor, 'T1~T4' represents the severity of primary cancer according to the increase in tumor 187 volume and the extent of involvement of adjacent tissues, and 'T0' indicates no primary tumor. 'N'
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188 represents the tumor spreading to regional lymph nodes. 'N1~N3' represents the degree of spreading 
